{
    "N/R/U": null,
    "Applicant": "ID Biomedical Corporation of Quebec",
    "BLA Number": "125419",
    "Proprietary Name": "Arepanrix",
    "Proper Name": "Influenza A (H5) Monovalent, Adjuvanted",
    "BLA Type": "351(a)",
    "Strength": "0.5ML",
    "Dosage Form": "Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Vial",
    "Marketing Status": "Disc",
    "Licensure": "Licensed",
    "Approval Date": "November 22, 2013",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "1739",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}